BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 31801363)

  • 1. Cost-Utility Analysis of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression in Ontario.
    Fitzgibbon KP; Plett D; Chan BCF; Hancock-Howard R; Coyte PC; Blumberger DM
    Can J Psychiatry; 2020 Mar; 65(3):164-173. PubMed ID: 31801363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: An Economic Analysis.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(6):1-51. PubMed ID: 27110317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of electroconvulsive therapy compared to repetitive transcranial magnetic stimulation for treatment-resistant severe depression: a decision model.
    Vallejo-Torres L; Castilla I; González N; Hunter R; Serrano-Pérez P; Perestelo-Pérez L
    Psychol Med; 2015 May; 45(7):1459-70. PubMed ID: 25354790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness Modeling of Repetitive Transcranial Magnetic Stimulation Compared to Electroconvulsive Therapy for Treatment-Resistant Depression in Singapore.
    Zhao YJ; Tor PC; Khoo AL; Teng M; Lim BP; Mok YM
    Neuromodulation; 2018 Jun; 21(4):376-382. PubMed ID: 29143405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repetitive Transcranial Magnetic Stimulation for People With Treatment-Resistant Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(4):1-232. PubMed ID: 34055112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.
    McLoughlin DM; Mogg A; Eranti S; Pluck G; Purvis R; Edwards D; Landau S; Brown R; Rabe-Heskith S; Howard R; Philpot M; Rothwell J; Romeo R; Knapp M
    Health Technol Assess; 2007 Jul; 11(24):1-54. PubMed ID: 17580003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-utility analysis of curative and maintenance repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant unipolar depression: a randomized controlled trial protocol.
    Bulteau S; Laurin A; Volteau C; Dert C; Lagalice L; Schirr-Bonnans S; Bukowski N; Guitteny M; Simons L; Cabelguen C; Pichot A; Tessier F; Bonnin A; Lepage A; ; ; Vanelle JM; Sauvaget A; Riche VP
    Trials; 2020 Apr; 21(1):312. PubMed ID: 32248820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
    Nguyen KH; Gordon LG
    Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of transcranial magnetic stimulation vs. electroconvulsive therapy for severe depression: a multi-centre randomised controlled trial.
    Knapp M; Romeo R; Mogg A; Eranti S; Pluck G; Purvis R; Brown RG; Howard R; Philpot M; Rothwell J; Edwards D; McLoughlin DM
    J Affect Disord; 2008 Aug; 109(3):273-85. PubMed ID: 18262655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision analysis of the cost-effectiveness of repetitive transcranial magnetic stimulation versus electroconvulsive therapy for treatment of nonpsychotic severe depression.
    Kozel FA; George MS; Simpson KN
    CNS Spectr; 2004 Jun; 9(6):476-82. PubMed ID: 15162090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of Electroconvulsive Therapy vs Pharmacotherapy/Psychotherapy for Treatment-Resistant Depression in the United States.
    Ross EL; Zivin K; Maixner DF
    JAMA Psychiatry; 2018 Jul; 75(7):713-722. PubMed ID: 29800956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of resistant major depressive disorder treatment in Iranian population: a comparison between repetitive Transcranial Magnetic Stimulation with electroconvulsive.
    Ghiasvand H; Moradi-Joo M; Abolhassani N; Ravaghi H; Raygani SM; Mohabbat-Bahar S
    Med J Islam Repub Iran; 2016; 30():330. PubMed ID: 27390700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The priming effect of repetitive transcranial magnetic stimulation on clinical response to electroconvulsive therapy in treatment-resistant depression: a randomized, double-blind, sham-controlled study.
    Rothärmel M; Quesada P; Husson T; Harika-Germaneau G; Nathou C; Guehl J; Dalmont M; Opolczynski G; Miréa-Grivel I; Millet B; Gérardin E; Compère V; Dollfus S; Jaafari N; Bénichou J; Thill C; Guillin O; Moulier V
    Psychol Med; 2023 Apr; 53(5):2060-2071. PubMed ID: 34579796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Non-inferiority Framework for Cost-Effectiveness Analysis.
    Xie X; Falk L; Brophy JM; Tu HA; Guo J; Gajic-Veljanoski O; Sikich N; Dhalla IA; Ng V
    Int J Technol Assess Health Care; 2019; 35(4):291-297. PubMed ID: 31337452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repetitive transcranial magnetic stimulation may be a cost-effective alternative to antidepressant therapy after two treatment failures in patients with major depressive disorder.
    Zemplényi A; Józwiak-Hagymásy J; Kovács S; Erdősi D; Boncz I; Tényi T; Osváth P; Voros V
    BMC Psychiatry; 2022 Jun; 22(1):437. PubMed ID: 35764989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(5):1-66. PubMed ID: 27099642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a systematic review and meta-analysis.
    Ren J; Li H; Palaniyappan L; Liu H; Wang J; Li C; Rossini PM
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():181-9. PubMed ID: 24556538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-utility analysis of adjunct repetitive transcranial magnetic stimulation for treatment resistant bipolar depression.
    Chatterton ML; Lee YY; Le LK; Nichols M; Carter R; Berk M; Mihalopoulos C
    J Affect Disord; 2024 Jul; 356():639-646. PubMed ID: 38657770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of intermittent theta burst stimulation compared to conventional repetitive transcranial magnetic stimulation in patients with treatment resistant depression: A cost analysis.
    Mendlowitz AB; Shanbour A; Downar J; Vila-Rodriguez F; Daskalakis ZJ; Isaranuwatchai W; Blumberger DM
    PLoS One; 2019; 14(9):e0222546. PubMed ID: 31513675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and acceptability of high frequency repetitive transcranial magnetic stimulation (rTMS) versus electroconvulsive therapy (ECT) for major depression: a systematic review and meta-analysis of randomized trials.
    Berlim MT; Van den Eynde F; Daskalakis ZJ
    Depress Anxiety; 2013 Jul; 30(7):614-23. PubMed ID: 23349112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.